Kristen Mengwasser, MD, PhD
|
| Title(s) | Assistant Professor, Medicine |
|---|
| School | School of Medicine |
|---|
| Address | 1001 Potrero Avenue, #4301
San Francisco CA 94110
|
|---|
| Pronouns | She/Her/Hers |
|---|
ORCID
.gif) | 0000-0003-3327-7711  |
|---|
| vCard | Download vCard |
|---|
|
|
Biography
| Harvard University, Cambridge, MA | BA | | Biochemical Sciences |
| University of Cambridge, UK | MPhil | | Biochemistry |
| Harvard University, Boston, MA | PhD | | Genetics |
| Harvard Medical School/MIT, Boston, MA | MD | | Medicine |
| Brigham and Women's Hospital, Boston, MA | Internal Medicine Residency | | Medicine |
| UCSF, San Francisco, CA | Rheumatology Fellowship | | Rheumatology |
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1. Proc Natl Acad Sci U S A. 2022 02 15; 119(7).
Oreskovic E, Wheeler EC, Mengwasser KE, Fujimura E, Martin TD, Tothova Z, Elledge SJ. PMID: 35149558; PMCID: PMC8851563.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCells
-
Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing. Cell Rep. 2019 09 24; 28(13):3435-3449.e5.
Elman JS, Ni TK, Mengwasser KE, Jin D, Wronski A, Elledge SJ, Kuperwasser C. PMID: 31553912; PMCID: PMC7297508.
View in:
PubMed Mentions:
21 Fields:
Translation:
HumansCells
-
Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. Mol Cell. 2019 03 07; 73(5):885-899.e6.
Mengwasser KE, Adeyemi RO, Leng Y, Choi MY, Clairmont C, D'Andrea AD, Elledge SJ. PMID: 30686591; PMCID: PMC6892393.
View in:
PubMed Mentions:
101 Fields:
Translation:
HumansCells
-
Functional genomics reveals that tumors with activating phosphoinositide 3-kinase mutations are dependent on accelerated protein turnover. Genes Dev. 2016 12 15; 30(24):2684-2695.
Davoli T, Mengwasser KE, Duan J, Chen T, Christensen C, Wooten EC, Anselmo AN, Li MZ, Wong KK, Kahle KT, Elledge SJ. PMID: 28087713; PMCID: PMC5238728.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansAnimalsCells
-
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013 Nov 07; 155(4):948-62.
Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, Elledge SJ. PMID: 24183448; PMCID: PMC3891052.
View in:
PubMed Mentions:
401 Fields:
Translation:
Humans
-
LPS ligand and culture additives improve production of monomeric MD-1 and 2 in Pichia pastoris by decreasing aggregation and intermolecular disulfide bonding. Protein Expr Purif. 2011 Apr; 76(2):173-83.
Mengwasser KE, Bryant CE, Gay NJ, Gangloff M. PMID: 21130168; PMCID: PMC3032050.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A. 2008 Feb 12; 105(6):2070-5.
Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ. PMID: 18227510; PMCID: PMC2538882.
View in:
PubMed Mentions:
721 Fields:
Translation:
AnimalsCells
-
Hirudin binding reveals key determinants of thrombin allostery. J Biol Chem. 2005 Jul 22; 280(29):26997-7003.
Mengwasser KE, Bush LA, Shih P, Cantwell AM, Di Cera E. PMID: 15923186.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2022 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs